Michael O'Donnell
Fortune : 10 584 $ au 31/05/2026
Fortune : 10 584 $ au 31/05/2026
Michael J.
O'Donnell is currently a Partner at Orrick Herrington & Sutcliffe LLP since 2021.
Former positions include Secretary & Independent Director at Filana Therapeutics, Inc. from 1998 to 2026, Member at Morrison & Foerster LLP from 2011 to 2021, Member at Wilson Sonsini Goodrich & Rosati PC from 1993 to 2011, Secretary at Solopoint.com, Inc., Secretary & Corporate Counsel at Edison Pharmaceuticals, Inc., Secretary at Labcyte, Inc., and Partner at WS Investment Management Co. Education includes graduate studies at Harvard University and undergraduate studies at Bucknell University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/04/2026 | 6 873 ( 0,01 % ) | 10 584 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Orrick Herrington & Sutcliffe LLP
Orrick Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm in technology, innovation, finance, energy and infrastructure sectors | Corporate Officer/Principal | 01/06/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| FILANA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/06/2026 |
Morrison & Foerster LLP
Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2021 |
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2011 |
Solopoint.com, Inc.
Solopoint.com, Inc. Data Processing ServicesTechnology Services Provides Internet broadband services | Secrétaire Général | 28/12/2010 |
Edison Pharmaceuticals, Inc.
Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mitochondrial diseases | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Solopoint.com, Inc.
Solopoint.com, Inc. Data Processing ServicesTechnology Services Provides Internet broadband services | Technology Services |
Cassava Sciences, Inc.
Cassava Sciences, Inc. BiotechnologyHealth Technology Manufactures and markets therapeutic products to detect and treat neurodegenerative diseases | Health Technology |
Edison Pharmaceuticals, Inc.
Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mitochondrial diseases | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Morrison & Foerster LLP
Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Orrick Herrington & Sutcliffe LLP
Orrick Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm in technology, innovation, finance, energy and infrastructure sectors | Commercial Services |
Bucknell University
Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Labcyte, Inc.
Labcyte, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology tools company that manufactures and markets echo liquid handling systems | Health Services |
WS Investment Management Co.
WS Investment Management Co. Investment ManagersFinance WS Investment invests in companies located in the United States. The firm targets companies operating in the fields of technology, life sciences, and renewable energy industries. It provides financing in the form of equity and mezzanine for early, later, growth, buyout, restructurings and recapitalizations, divisional spin-offs & carve outs. It also invests in public companies. | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national